James Fox, MD
Ophthalmology · Grand Junction, CONPI 1295997351
Payments from drug & device makers
Across 371 payments — averaging $2476.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$686K
- Bausch Health US, LLC$144K
- Alcon Research LLC$65K
- AbbVie$21K
- Alcon$1K
- NEW World Medical,inc.$357
- plus $2K from 16 others
Across 1 payment — averaging $3990.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 247 | $685,668 |
| Bausch Health US, LLC | 9 | $144,450 |
| Alcon Research LLC | 2 | $64,821 |
| AbbVie(2 entities) | 14 | $20,691 |
| Alcon | 34 | $1,032 |
| NEW World Medical,inc. | 3 | $357 |
| Rxsight Inc | 5 | $251 |
| Rayner Intraocular Lenses Limited | 5 | $221 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $211 |
| Kala Pharmaceuticals, Inc. | 8 | $162 |
| Sun Pharmaceutical Industries Inc. | 8 | $139 |
| Novartis | 7 | $135 |
| Sight Sciences, Inc. | 6 | $117 |
| Boston Scientific | 3 | $66 |
| Biotissue Holdings Inc. | 4 | $58 |
| Tarsus Pharmaceuticals, Inc. | 3 | $56 |
| Oyster Point Pharma, Inc. | 2 | $49 |
| Harrow Eye, LLC | 3 | $48 |
| Beaver-visitec International, Inc. | 1 | $36 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
How this compares
$918,624 in reported general payments places this provider in the 95th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Grand Junction
- Mark PackerBoulder$6.6M
- Ryan RichColorado Springs$2.1M
- Michael JansenDenver$1.8M
- Curtis HagedornDenver$1.5M
- Cristos IfantidesDenver$1.4M
- Jon DishlerGreenwood Village$1.1M
- Mark DaceyDenver$798K
- Peter HovlandDenver$568K
- Kent CrewsFort Collins$502K
- James LeeColorado Springs$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.